FDA Import Refusal SCS-2242043-8/11/3 — TANIA MARIA MOURA
The FDA refused shipment SCS-2242043-8/11/3 from TANIA MARIA MOURA (Brazil) on Jan 26, 2024. The refused product falls under Drugs and Biologics — CLONAZEPAM (ANTI-CONVULSANT). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Jan 26, 2024
- Country
- Brazil
- Product Category
- Drugs and Biologics
- Product Code
- 61MCY06 CLONAZEPAM (ANTI-CONVULSANT)
- Charges
- 75